Kathryn Lowe
VenatoRx Pharmaceuticals (United States)(US)
Publications by Year
Research Areas
Autism Spectrum Disorder Research, Antibiotics Pharmacokinetics and Efficacy, Genetics and Neurodevelopmental Disorders, Virology and Viral Diseases, Pharmacological Effects and Toxicity Studies
Most-Cited Works
- → SPARK: A US Cohort of 50,000 Families to Accelerate Autism Research(2018)480 cited
- → Clinical Genetic Testing for Patients With Autism Spectrum Disorders(2010)393 cited
- → Characteristics and Predictive Value of Blood Transcriptome Signature in Males with Autism Spectrum Disorders(2012)169 cited
- → Pharmacokinetics and safety of single and repeat doses of ceftibuten in healthy participants: a phase 1 dose escalation study(2025)
- → Safety and pharmacokinetics of single and multiple doses of ledaborbactam etzadroxil with or without ceftibuten in healthy volunteers(2025)
- → P-1230. Dose-Escalation Study to Evaluate the Pharmacokinetics and Safety of Single and Repeat Doses of Ceftibuten in Healthy Participants(2025)
- → P-1243. Evaluation of Single and Multiple Dose Safety and Pharmacokinetics of Ledaborbactam Etzadroxil and Ceftibuten-Ledaborbactam Etzadroxil in Healthy Volunteers(2025)